PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v8i6.8881ArticleInhibition of Cancer Cell Growth by Baicalein via ESR1 Based on Molecular Dynamics Simulationshttps://artdesignp.com/journal/PAR/8/6/10.26689/par.v8i6.8881KangChao,WangMengke,ZhangYongsong2024862024-11-22This study investigates the mechanism by which baicalin inhibits cancer cell growth through estrogen receptor 1 (ESR1) using molecular dynamics simulations. The results show that baicalin primarily binds to the ligand-binding domain (LBD) of ESR1, interacting through hydrogen bonds and hydrophobic interactions. After binding, the overall and local conformations of ESR1 change, affecting its interactions with other proteins and thus modulating the signaling pathways of cancer cells. Binding free energy analysis indicates that the binding of baicalin to ESR1 is spontaneous and relatively stable. Additionally, baicalin can inhibit the binding of ESR1 to estrogen, blocking the estrogen signaling pathway and thereby suppressing the growth and proliferation of cancer cells. This study provides theoretical and experimental foundations for the potential use of baicalin as an anticancer drug, offering new insights and methods for the development of novel anticancer drugs. However, the study has some limitations, such as limited simulation time and simplified systems. Future research can extend the simulation time and consider more physiological factors to more accurately simulate the interactions between baicalin and ESR1.

Laxminarayan R, Matsoso P, Pant S, et al., 2016, Access to Effective Antimicrobials: A Worldwide Challenge. The Lancet, 387(10014): 168–175.

Choi SH, Seong J, 2018, Strategic Application of Radiotherapy for Hepatocellular Carcinoma. Clinical and Molecular Hepatology, 24(2): 114–134.

Knezevic CE, Clarke W, 2020, Cancer Chemotherapy: The Case for Therapeutic Drug Monitoring. Therapeutic Drug Monitoring, 42(1): 6–19.

Zeng Y, Liao X, Guo Y, et al., 2024, Baicalin-Peptide Supramolecular Self-Assembled Nanofibers Effectively Inhibit Ferroptosis and Attenuate Doxorubicin-Induced Cardiotoxicity. Journal of Controlled Release, 366: 838–848.

Li Y, Song K, Zhang H, et al., 2020, Anti-Inflammatory and Immunomodulatory Effects of Baicalin in Cerebrovascular and Neurological Disorders. Brain Research Bulletin, 164: 314–324.

Zhao D, Du B, Xu J, et al., 2022, Baicalin Promotes Antibacterial Defenses by Modulating Mitochondrial Function. Biochemical and Biophysical Research Communications, 621: 130–136.

Ng CW, Tsang YTM, Gershenson DM, et al., 2024, The Prognostic Value of MEK Pathway-Associated Estrogen Receptor Signaling Activity for Female Cancers. British Journal of Cancer, 130(11): 1875–1884.

Yu M, Bardia A, Aceto N, et al., 2014, Cancer Therapy: Ex Vivo Culture of Circulating Breast Tumor Cells for Individualized Testing of Drug Susceptibility. Science, 345: 216–220.

Bai G, Pan Y, Zhang Y, et al., 2023, Research Advances of Molecular Docking and Molecular Dynamic Simulation in Recognizing Interaction Between Muscle Proteins and Exogenous Additives. Food Chemistry, 429: 136836.

Al-Khafaji K, Taskin Tok T, 2020, Molecular Dynamics Simulation, Free Energy Landscape, and Binding Free Energy Computations in Exploration of the Anti-Invasive Activity of Amygdalin Against Metastasis. Computers in Biology and Medicine, 195: 105660.

Bekhit AE, Faustman C, 2005, Metmyoglobin Reducing Activity. Meat Science, 71(3): 407–439.